Chronic Liver Disease

Chronic liver disease progression involves the hepatic growth hormone receptor

Published in Hepatitis Weekly, July 10th, 2006

Researchers in Italy reported that hepatitis C virus (HCV)-related chronic liver disease progression involves a subcellular shift of the hepatic growth hormone receptor (GHR).

U.V. Gentilucci and colleagues, University of Rome Campus of Biomedicine, wrote that the study was done "to evaluate the cytoplasmic and nuclear expression of hepatic growth hormone receptor (GHR) in different stages (S-0, S-1, S-3 and S-4, according to Knodell's classification) of chronic liver disease (CLD) and in hepatocellular carcinoma (HCC)."

"Liver specimens from 31 patients with hepatitis C virus-related CLD, five patients with HCC and nine controls were examined for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2006-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database